These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 33711759)
1. Clinical Outcomes and Medical Costs of Hydration Therapy with Hydroxyethyl Starch (130/0.4) or Acute Single Infarction. Fujita A; Matsuzaka M; Metoki N; Hagii J; Shiroto H; Iwata M; Tanaka R; Tsuda E J Stroke Cerebrovasc Dis; 2021 May; 30(5):105705. PubMed ID: 33711759 [TBL] [Abstract][Full Text] [Related]
2. Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial. Rasmussen KC; Johansson PI; Højskov M; Kridina I; Kistorp T; Thind P; Nielsen HB; Ruhnau B; Pedersen T; Secher NH Ann Surg; 2014 Feb; 259(2):249-54. PubMed ID: 24100337 [TBL] [Abstract][Full Text] [Related]
3. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long-term outcomes and cost-effectiveness analysis of a cohort from CHEST. Taylor C; Thompson K; Finfer S; Higgins A; Jan S; Li Q; Liu B; Myburgh J; Lancet Respir Med; 2016 Oct; 4(10):818-825. PubMed ID: 27324967 [TBL] [Abstract][Full Text] [Related]
4. Effect of 6% Hydroxyethyl Starch 130/0.4 on Inflammatory Response and Pulmonary Function in Patients Having Cardiac Surgery: A Randomized Clinical Trial. Lee MJ; Tannenbaum C; Mao G; Jia Y; Leung S; Yilmaz HO; Ince I; Soltesz E; Duncan AE Anesth Analg; 2021 Oct; 133(4):906-914. PubMed ID: 34406128 [TBL] [Abstract][Full Text] [Related]
5. Hydroxyethyl starch for fluid resuscitation in critically ill patients. Bagshaw SM; Chawla LS Can J Anaesth; 2013 Jul; 60(7):709-13. PubMed ID: 23604905 [TBL] [Abstract][Full Text] [Related]
6. Safety evaluation on low-molecular-weight hydroxyethyl starch for volume expansion therapy in pediatric patients: a meta-analysis of randomized controlled trials. Li L; Li Y; Xu X; Xu B; Ren R; Liu Y; Zhang J; He B Crit Care; 2015 Mar; 19(1):79. PubMed ID: 25887704 [TBL] [Abstract][Full Text] [Related]
7. Hydroxyethyl starch for volume expansion after subarachnoid haemorrhage and renal function: Results of a retrospective analysis. Bercker S; Winkelmann T; Busch T; Laudi S; Lindner D; Meixensberger J PLoS One; 2018; 13(2):e0192832. PubMed ID: 29447255 [TBL] [Abstract][Full Text] [Related]
8. Association of high volumes of hydroxyethyl starch with acute kidney injury in elderly trauma patients. Leberle R; Ernstberger A; Loibl M; Merkl J; Bunz M; Creutzenberg M; Trabold B Injury; 2015 Jan; 46(1):105-9. PubMed ID: 25240412 [TBL] [Abstract][Full Text] [Related]
9. Postoperative renal morbidity and mortality after volume replacement with hydroxyethyl starch 130/0.4 or albumin during surgery: a propensity score-matched study. Miyao H; Kotake Y J Anesth; 2020 Dec; 34(6):881-891. PubMed ID: 32783070 [TBL] [Abstract][Full Text] [Related]
10. Why hydroxyethyl starch solutions should NOT be banned from the operating room. De Hert S; De Baerdemaeker L Anaesthesiol Intensive Ther; 2014; 46(5):336-41. PubMed ID: 25432553 [TBL] [Abstract][Full Text] [Related]
11. European hydroxyethyl starch: a safe and inexpensive alternative to albumin. Treib J; Haass A; Schimrigk K Anesth Analg; 1997 Sep; 85(3):709. PubMed ID: 9296444 [No Abstract] [Full Text] [Related]
12. Changes in Serum Creatinine Concentration and Acute Kidney Injury (AKI) Grade in Dogs Treated with Hydroxyethyl Starch 130/0.4 From 2013 to 2015. Sigrist NE; Kälin N; Dreyfus A J Vet Intern Med; 2017 Mar; 31(2):434-441. PubMed ID: 28109131 [TBL] [Abstract][Full Text] [Related]
13. Effects of Hydroxyethyl Starch 130/0.4 on Serum Creatinine Concentration and Development of Acute Kidney Injury in Nonazotemic Cats. Sigrist NE; Kälin N; Dreyfus A J Vet Intern Med; 2017 Nov; 31(6):1749-1756. PubMed ID: 28862347 [TBL] [Abstract][Full Text] [Related]
14. Renal Morbidity of 6% Hydroxyethyl Starch 130/0.4 in 9000 Propensity Score Matched Pairs of Surgical Patients. Miyao H; Kotake Y Anesth Analg; 2020 Jun; 130(6):1618-1627. PubMed ID: 31856004 [TBL] [Abstract][Full Text] [Related]
15. Retrospective cohort study on the incidence of acute kidney injury and death following hydroxyethyl starch (HES 10% 250/0.5/5:1) administration in dogs (2007-2010). Hayes G; Benedicenti L; Mathews K J Vet Emerg Crit Care (San Antonio); 2016; 26(1):35-40. PubMed ID: 26587795 [TBL] [Abstract][Full Text] [Related]
16. Initial administration of hydroxyethyl starch vs lactated Ringer after liver trauma in the pig. Zaar M; Lauritzen B; Secher NH; Krantz T; Nielsen HB; Madsen PL; Johansson PI Br J Anaesth; 2009 Feb; 102(2):221-6. PubMed ID: 19074153 [TBL] [Abstract][Full Text] [Related]
17. Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution. Ickx BE; Bepperling F; Melot C; Schulman C; Van der Linden PJ Br J Anaesth; 2003 Aug; 91(2):196-202. PubMed ID: 12878617 [TBL] [Abstract][Full Text] [Related]
18. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Kasper SM; Meinert P; Kampe S; Görg C; Geisen C; Mehlhorn U; Diefenbach C Anesthesiology; 2003 Jul; 99(1):42-7. PubMed ID: 12826840 [TBL] [Abstract][Full Text] [Related]
19. Hydroxyethyl Starch 130/0.4 and the Risk of Acute Kidney Injury After Cardiopulmonary Bypass: A Single-Center Retrospective Study. Lagny MG; Roediger L; Koch JN; Dubois F; Senard M; Donneau AF; Hubert MB; Hans GA J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):869-75. PubMed ID: 26774199 [TBL] [Abstract][Full Text] [Related]
20. Is Hydroxyethyl Starch Safe in Penetrating Trauma Patients? Allen CJ; Ruiz XD; Meizoso JP; Ray JJ; Livingstone AS; Schulman CI; Namias N; Proctor KG Mil Med; 2016 May; 181(5 Suppl):152-5. PubMed ID: 27168566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]